We found a population of nonlymphoid cells expressing both CD4 and CD8 in PBMCs of human T cell leukemia virus type-I pX transgenic rats with autoimmune diseases. These cells, which showed a monocytic phenotype, were found also in wild-type rats, and their number increased by adjuvant-assisted immunization. GM-CSF increased the number of these cells in PBMCs.
Introduction
Despite their origin from a common bone marrow progenitor population, cells of the monocytes/macrophage lineage display considerable phenotypic and functional heterogeneity. Thus, macrophages residing in the liver and the lungs differ in their basal activity as well as their ability to respond to inflammatory mediators. Even within a single organ, macrophages are heterogeneous; macrophages localized in the centrilobular and periportal regions of the liver differ in size, the ability to produce superoxide anion, and phagocytic activities. 1 In an inflammatory response, the early stages are dominated by macrophages showing inflammatory and tissue-destructive activities, and in the late stages, macrophages with tissue-restructuring activities predominate. 2 In tumor tissues, infiltrating macrophages tend to acquire a polarized M2 phenotype, promoting tumor growth and progression. 3 Accumulated evidence indicates that such macrophage heterogeneity is largely attributable to microenvironmental signals including cytokines and microbial products.
Although this suggests that macrophages do not have stable, lineage-defined subsets, and that their functional phenotypes change in response to a microenvironment, definitions of macrophage subpopulations are important not only for understanding their role in host defense and disease pathogenesis, but also for designing effective therapeutic interventions.
In our previous study, we made F1 rats by mating F344 transgenic rats expressing the human T cell leukemia virus type-I (HTLV-I) pX gene 4 to nontransgenic Wistar rats and found that they developed disorders, including atrophy of the thymus, lymphocytopenia, and inflammatory cell infiltration into multiple organs, as typically seen in chronic graft-versus-host disease (GVHD). 5 In these rats (hereafter referred to as FW-pX rats), the HTLV-I pX transgene induced neonatal apoptosis of the thymic epithelial cells, resulting in lymphocytopenia accompanied by compensatory expansion of peripheral myeloid cells, production of autoreactive T cells, and subsequent development of chronic GVHD-like autoimmune diseases.
In the present study, we found that a population of monocytic cells expressing both CD4
and CD8 was expanded in the peripheral blood of FW-pX rats. Monocytes/macrophages Baba et al CD4/CD8 DP MONOCYTE/MACROPHAGE 4 constitutively express CD4 in humans and rats 6, 7 but not in mice. On the other hand, part of myeloid cells including natural killer (NK) cells, mast cells, macrophages, and dendritic cells (DCs) express CD8. [8] [9] [10] [11] [12] [13] [14] We therefore hypothesized that rat peripheral blood contains a population of monocytes expressing both CD4 and CD8, and that this population is expanded under certain activating conditions. To test this hypothesis, we used a rat model of myosin-induced myocarditis. Here we show that the number of CD4/CD8 double-positive (DP) monocytes is indeed increased by adjuvant-assisted immunization with myosin or by administration of adjuvants alone, and that these cells express cytotoxic factors such as perforin and granzyme B, and exhibit cytotoxicity against tumor cells in vitro. Approximately half of the macrophages that infiltrated the cardiac lesion expressed both CD4 and CD8; these DP macrophages, shown to be of hematogenous origin by adoptive transfer experiments, expressed Fas ligand (Fas L), perforin, and granzyme B at high levels. Thus, our present work demonstrates the existence of a distinct population of monocytes/macrophages characterized by co-expression of CD4 and CD8, and a cytotoxic phenotype. Interestingly, human peripheral blood also contains DP monocytes.
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Materials and Methods
Rats
FW-pX rats were obtained by mating male F344 transgenic rats expressing the HTLV-I pX gene without any tissue-specificity (line 38) 4 to nontransgenic female Wistar rats. Offspring were screened for the pX transgene by genomic PCR as described. 4 FW-wild-type (FW-wt) rats were obtained by mating nontransgenic male F344 rats to female Wistar rats. HTLV-I pX transgenic rats (line 38) were maintained at the Institute of Animal Experimentation, Hokkaido University Graduate School of Medicine. Inbred F344 and closed colony Wistar rats were purchased from SLC (Shizuoka, Japan) and Charles River (Kanagawa, Japan), respectively. The EGFP transgenic rats that ubiquitously expressed green fluorescent protein (GFP) 15 were obtained from the YS Institute (Utsunomiya, Japan) and Tohoku University (Sendai, Japan). All experiments using rats were done
according to the Guideline for the Care and Use of Laboratory Animals in Hokkaido University
Graduate School of Medicine (http://www.hokudai.ac.jp/animal/houki/hokudaisisin.html).
Human blood samples
Human blood samples were obtained from 12 healthy donors after informed consent and used for flow cytometry (FCM). Nobody had medical histories of autoimmune diseases, recent infection, or neoplasms.
Antibodies (Abs)
Murine monoclonal Abs used were anti-rat CD3 (IF4 for immunohistochemistry; Cedarlane, Fornby, Canada, and G4.18 for FCM; Pharmingen, SanDiego, CA), CD4 (OX-35; Pharmingen), CD8
H-chain hinge region (OX-8; Pharmingen), CD8 H-chain immunoglobulin (Ig) V-like region (G28; Pharmingen), CD8 I-chain (341; Pharmingen), CD11b/c (OX-42; Pharmingen), CD68 (ED-1; Serotec, Oxford, UK), CD163 (ED-2; Serotec), B cell (RLN-9D3; Serotec), DC (OX-62; Cedarlane), and NKR-P1A (10/78; Pharmingen), as well as anti-human CD4 (M-T466; Miltenyi Biotec, Bergisch Gladbach, Germany), CD8 (HIT8a; Pharmingen), and CD14 (MJP9; Pharmingen). Louis, MO) served as controls.
Recombinant cytokines/chemokines
Recombinant cytokines/chemokines used were rat RANTES and GM-CSF (PEPROTECH EC, London, UK), and mouse IL-12 (RዊD Systems, Mineapolis, MN) previously shown to function in rats. 16 For in vivo administration, GM-CSF (1.0 µg per 1 ml PBS) was injected intravenously into 6-week-old Wistar rats. Peripheral blood was assayed 24 hours after injection.
FCM and magnetic activated cell sorting (MACS)
Peripheral blood cells were stained by the direct method without removal of serum. After reaction with Abs, erythrocytes were depleted by treatment with ammonium chloride. Expression of cell surface molecules was analyzed using FACScan (Becton Dickinson, Franklin Lakes, NJ) with CellQuest software (Becton Dickinson). MACS was done using Magnetic Cell Separator (Miltenyi Biotec) as described.
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Phagocytosis assay
Yellow-green carboxylate-modified 1.0 µm latex beads (Sigma-Aldrich) were mixed with rat peripheral blood (1.5 x 10 7 beads/300 µl blood). After incubation for 2 hours at 37MC, PE-conjugated anti-CD4 (OX-35) and PerCP-conjugated anti-CD8 (OX-8) Abs were added to the mixture, followed by depletion of erythrocytes using ammonium chloride. After 3 times wash with cold PBS, CD4/CD8 DP cells were gated to determine uptake of the fluorescence-labeled beads using FACScan.
Immunization of rats with porcine heart myosin and induction of myocarditis
Killed tuberculosis germs were added to Freund's incomplete adjuvant (Sigma-Aldrich) to reach the concentration of 100 mg/ml. Two milligrams of myosin from porcine heart (Sigma-Aldrich) were emulsified with an equal volume (200 µl) of the prepared adjuvant. The emulsion containing porcine myosin was inoculated into bilateral footpads of 3-week-old FW-wt rats (200 µl/site).
Histopathology and immunohistochemistry
Tissue samples were fixed in 10% phosphate-buffered formaldehyde and embedded in paraffin blocks. Each 4 µm section was stained with hematoxylin and eosin. For immunohistochemistry, an avidin-biotin immunoperoxidase kit (DAKO, Glostrup, Denmark) was used. After immunostaining, tissue sections were counter-stained with Mayer's hematoxylin (Merck, Darmstadt, Germany).
Isolation of macrophages from cardiac tissues with myocarditis
At 3 weeks after myosin-immunization, the heart was extirpated and then perfused by PBS ex vivo.
The cardiac tissues were cut into small pieces and digested by 0.16% collagenase type II (Worthington Biochemical Corporation, Lakewood, NJ). After removal of tissue fragments, cell suspension was incubated in a plastic dish at 37MC. One hour later, adherent cells were harvested and used as tissue-infiltrating macrophages. The purity of ED-1 (CD68)-positive cells regarded as macrophages was 94% (data not shown).
Immunocytochemistry
Mononuclear cells separated from rat spleen using Histopaque-1083 (Sigma-Aldrich) or isolated from cardiac tissues were cultured in chamber slides (Nalge Nunc International, Roskilde, Denmark), respectively, for 1 hour. Resultant adherent cells were fixed using cold acetone for 5 min or 4% paraformaldehyde for 15 min at room temperature, and then stained by the standard method (for details, see the figure legends). After washing with PBS, the slides were mounted in FLUORESCENT MOUNTING MEDIUM (DAKO). Immunofluorescence was detected using a confocal microscope (MRC-1024; BIO-RAD, Hercules, CA) or a fluorescence microscope The expression level of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an internal control. PCR was conducted for 40 cycles using an ABI PRISM 7000 Sequence Detector System (Applied Biosystems) with two-step reactions (95MC for 30 sec, 60MC for 30 sec) after initial denaturation of 95MC for 15 min. The primer sequences for PCR are listed in Table 1 .
Transfer of GFP-positive spleen cells into nontransgenic recipients
The EGFP transgenic rats and nontransgenic Wistar rats (4-weeks-old, respectively) were immunized with porcine myosin as described above. Mononuclear cells were isolated from the spleen of EGFP transgenic rats one week after immunization, and transferred into Wistar rats that had been immunized with myosin two weeks before (1 x 10 7 /rat/i.v.). Five days later, the heart of the recipients was extirpated, and tissue-infiltrating macrophages were isolated.
Cytotoxic assay
Six-week-old Wistar rats were immunized with adjuvants containing killed tuberculosis germs. One week later, mononuclear cells were separated from the spleen, and incubated in plastic dishes for 20 min at 37MC. Resultant adherent cells were collected, and then divided into CD8 -and CD8 + cells using the MACS system. These cells were added to the culture of allogenic epithelial thymoma cells
(originated from F344 rats carrying the HTLV-I pX transgene 19 ) with E/T ratios of 30, 10, 1, and 0.1 (4 x 10 4 target cells per well in 24-well plates). After incubation for 18 hours, cytotoxicity was measured using the CytoTox 96 test kit (Promega, Madison, WI).
Statistical analysis
Data were represented as mean ± standard deviation (SD). Statistical significance between any two groups was determined by two-tailed Student's t test. P-values less than 0.05 were considered to be significant.
Results
Expansion of CD4/CD8 DP cells in the peripheral blood of FW-pX rats with chronic GVHD-like autoimmune diseases
In FW-pX rats, the HTLV-I pX transgene induced atrophy of the thymus, resulting in lymphocytopenia, production of autoreactive T cells, and subsequent development of chronic GVHD-like autoimmune diseases. whereas Nascimbeni et al. showed that some CD4/CD8 DP T cells expressed CD4 at a medium level. 20 Thus, we decided to examine whether CD4/CD8 DP cells in FW-pX rats were monocytes or T cells.
CD4/CD8 DP cells in the peripheral blood of FW-pX rats are monocytes
Peripheral blood was obtained from 6-week-old FW-pX rats. At first, we gated CD4/CD8 DP cells and confirmed that these cells were mononuclear but not aggregated cells ( Figure 2A ). Since rat monocytes could not be separated from lymphocytes or NK cells according to the light scatter pattern alone, we examined the expression of surface markers specific for each type of cells.
Histograms were obtained by gating of CD4/CD8 DP cells ( Figure 2B ). Most CD4/CD8 DP cells in FW-pX rats were CD11b/c high and NKR-P1A low , but did not express CD3. CD11b/c is expressed on monocytes, granulocytes, and macrophages, thereby known as a marker of myeloid cells. 21 NKR-P1A is highly expressed on NK cells and part of T cells, but expressed on monocytes at a low level. 22, 23 We additionally found that the CD4/CD8 DP cells did not express OX-62, a marker for DCs 24 (data not shown). These observations suggest that these DP cells have a monocytic but not T, NK, or DC phenotype. To further confirm this suggestion, adherent splenocytes from 6-week-old FW-pX rats were stained for OX-35 (anti-CD4), OX-8 (anti-CD8), and ED-1 (anti-CD68, as a marker for monocytes/macrophages 25, 26 ), and then observed using a confocal microscope. The three-color merged image indicates that the CD4/CD8 DP cells also express CD68 ( Figure 2C ). It is known that human CD68 can be expressed in activated T and B cells at a low level. 27, 28 However, there was no CD68 + population that expressed CD3 or the B cell marker, RLN-9D3, in our rat model. We therefore designated these DP cells as CD4/CD8 DP monocytes. In addition, we noted that CD4 and CD8 were distributed not only on the cell surface but also in the cytoplasm of DP monocytes. These findings are consistent with the previous observation that CD4 is expressed also in the cytoplasm of human monocytes. 29 The majority of CD8 molecules are heterodimers composed of H-and I-chains. On the other hand, a subset of T cells and most NK cells are known to express CD8 as homodimers of H-chains. 30 Hirji et al. showed that rat alveolar and peritoneal macrophages express CD8 as HI heterodimers but these CD8 molecules do not react with the anti-CD8 H-chain Ig V-like region Ab (G28). 13 Since the anti-CD8 H-chain hinge region Ab (OX-8) can recognize macrophage CD8, these authors suggested that the Ig V-like region of the CD8 H-chain was masked or modified on rat alveolar and peritoneal macrophages. To analyze the subunit organization of CD8 molecules expressed on the CD4/CD8 DP monocytes, we performed two-color FACS analysis using the anti-CD4 (OX-35) and three kinds of anti-CD8 Abs, including OX-8, G28, and anti-I-chain Abs (341). Histograms were obtained by gating of CD4 medium cells in PBMCs isolated from 6-week-old FW-pX rats ( Figure 2D ). The percentage of cells reactive with OX-8 (74.9%) was comparable to that stained with G28 (73.5%). The CD8 I-chain was expressed in 64.7% of CD4 medium cells. Thus, CD8 molecules expressed on the surface of CD4/CD8 DP monocytes in FW-pX rats are heterodimers composed of the I-chain and the H-chain with the conserved Ig V-like region.
Induction of CD4/CD8 DP monocytes in nontransgenic FW-wt rats
To examine whether CD4/CD8 DP monocytes are induced exclusively in FW-pX rats carrying the HTLV-I pX gene or also in other inflammatory situations unrelated to the transgene, we inoculated porcine myosin into the footpads of 3-week-old FW-wt rats, along with the adjuvant containing killed tuberculosis germs. It is known that CD4 1±14.6% and 23.5±16.3%, respectively). These findings indicate that CD4/CD8 DP monocytes can be induced in rats without any influence of the pX transgene, and suggest that they may be induced in an acute inflammatory phase.
To investigate the induction mechanisms of CD4/CD8 DP monocytes, we next immunized inbred F344 rats with various combinations of individual components used for initial immunization.
When rats were immunized with the adjuvant containing killed tuberculosis germs, the percentage of CD8 + population in CD4 medium cells was increased in the largest scale, though significant differences were observed by addition of any of the components (incomplete adjuvant only, an increase of 7.7%; adjuvant plus killed tuberculosis germs, an increase of 21.4%; myosin plus adjuvant plus killed tuberculosis germs, an increase of 29.9%) ( Figure 3D ). This suggested that immunization with tuberculosis germs might be critical for the induction of CD4/CD8 DP monocytes. To test this hypothesis, we examined whether the cytokines and chemokines known to be induced by the recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) [32] [33] [34] can induce CD4/CD8 DP monocytes in vitro. PBMCs from F344 rats were stimulated with IL-12, RANTES, or GM-CSF for 24 hours, and then the percentage of CD4/CD8 DP monocytes was measured. Among these cytokine/chemokines, only GM-CSF could induce CD4/CD8 DP monocytes in a dose-dependent manner ( Figure 3E ). We also observed that the percentage of CD4/CD8 DP monocytes (CD4 medium CD8 + population in PBMCs) was increased from 7.8 to 11.0%
by in vivo administration of GM-CSF. However, stimulation of bone marrow cells by GM-CSF failed to induce any significant expansion of CD4/CD8 DP cells (data not shown).
Infiltration of CD4/CD8 DP cells at the site of myocarditis
In myosin-immunized FW-wt rats, myocarditis occurred 3-4 weeks after immunization ( Figure 4A ).
At the site of inflammation, macrophages (reactive with ED-1, Figure 4B ) infiltrated more abundantly than CD3 + T cells ( Figure 4C ). To determine if infiltrating cells contained CD4/CD8 DP macrophages, adherent cells were isolated from collagenase-digested cardiac tissues, and subjected to immunocytochemical analysis. Half of macrophages (reactive with ED-1) expressed both CD4 and CD8 ( Figures 4D, 4E, 4F , and 4G). These CD4/CD8 DP macrophages were not reactive with ED-2 (a marker for tissue-resident macrophages 25 ) or OX-62 (a marker for DCs) (data not shown).
Thus, infiltrating CD4/CD8 DP macrophages are neither tissue-resident macrophages nor DCs, but are derived from the blood.
Cytokine/chemokine profiles and the cytotoxic phenotype of CD4/CD8 DP macrophages
We isolated adherent cells from rat cardiac tissues affected with myocarditis and separated CD4/CD8 DP macrophages from other, practically CD8 
CD4/CD8 DP monocytes are precursors of DP macrophages
To determine if CD4/CD8 DP monocytes in the blood migrated into sites of inflammation and differentiated to CD4/CD8 DP macrophages, transfer of GFP-positive spleen cells was made into nontransgenic rats immunized with myosin. GFP-positive macrophages were found in cardiac tissues with myocarditis ( Figure 6A ), and some GFP-positive macrophages expressed both CD4 and CD8 ( Figure 6B ). Furthermore, when the profiles of CD4/CD8 DP monocytes and CD4/CD8 DP macrophages were compared by RT-PCR, the expression patterns of Fas L, perforin, and granzyme B were similar ( Figure 6C ). On the other hand, the expression of NKR-P2 (rat orthologue of human NKG2D 35 ) known to play an important role in killing by NK cells and cytotoxic T lymphocytes (CTLs) 36, 37 was higher only in CD4/CD8 DP macrophages. These findings suggest that CD4/CD8 DP monocytes are precursors of tissue-infiltrating DP macrophages with a cytotoxic phenotype. In our experiments, evaluation of contaminated CD8 + CTLs was critical. As previously described, the purity of macrophages in the cells recovered from the cardiac tissues with myocarditis was 94% (see Materials and Methods). We therefore used a mixed cDNA sample (a mixture of CD8 Figure 6D ).
Cytotoxic function of CD4/CD8 DP monocytes
In order to evaluate the function of CD4/CD8 DP monocytes, we carried out in vitro cytotoxic assays against allogenic tumor cells. As a source of CD4/CD8 DP monocytes, we used CD8 
Phagocytic ability of CD4/CD8 DP monocytes
To determine the phagocytic ability of CD4/CD8 DP monocytes, yellow-green carboxylate-modified 1.0 µm latex beads were mixed with peripheral blood from Wistar rats that had been immunized with adjuvants containing killed tuberculosis germs one week before (1.5 x 10 7 beads/300 µl blood). After incubation for 2 hours at 37MC, uptake of fluorescence-labeled beads in CD4/CD8 DP monocytes was assayed using FACScan ( Figure 6F ). The painted histogram 
Discussion
In the present study, we have identified a population of monocytes/macrophages characterized by co-expression of CD4 and CD8. This population was originally identified in FW-pX rats carrying the HTLV-I pX transgene (Figures 1 and 2 ), but later found to be present in wild-type rats (Figure 3 ).
The number of CD4/CD8 DP monocytes showed a dramatic increase in rats with myosin-induced myocarditis ( Figure 3 ) and the DP macrophages were predominant infiltrating cells at the cardiac lesion ( Figure 4) . The most notable feature characterizing this population of macrophages is that they express high levels of Fas L, perforin, granzyme B ( Figures 5C and 5D ), and NKR-P2 ( Figure   6C ). In particular, granzyme B was expressed at an extremely high level (45.9-fold) in DP macrophages as compared to CD8 -macrophages ( Figure 5C ). NKG2D is the receptor previously shown to be expressed on NK cells, CTLs, and activated macrophages. Another notable feature of CD4/CD8 DP macrophages is that they express IL-18, IFN-R, and RANTES at higher levels, and MCP-1 at a lower level than CD8 -macrophages ( Figure 5B ).
IL-18, IFN-R, and RANTES induce the Th1-type immune response, 33, 39, 40 whereas MCP-1 induces the Th2-type immune response. 41 Although we were unable to detect CD3 mRNA by RT-PCR in our macrophage samples ( Figure 6C ), contamination of a small number of T/NK cells cannot be ruled out. Therefore, we should keep in mind the possibility that the cytokine production profiles (Fig.   5B ) may have been affected by contaminating T/NK cells; this reservation applies especially to IFN-, a cytokine typically produced by T/NK cells. However, we can say that tissue-infiltrating CD4/CD8 DP macrophages are prone to induce IL-18 and Th1-type immune responses at the site of inflammation. Okura et al. reported that Th1 cytokines were the major cytokines detected in the early phase of myosin-induced experimental myocarditis in rats. 42 Our present study indicates that CD4/CD8 DP macrophages infiltrating in the cardiac lesion may enhance the Th1-type immune response observed in the early phase of myosin-induced myocarditis.
The number of CD4/CD8 DP monocytes showed a dramatic increase by immunization with myosin ( Figures 3B and 3C) . When we examined which component in the immunogen was critical for increasing the population of DP monocytes, we found that the killed tuberculosis germs were the most effective factors ( Figure 3D ). BCG containing killed tuberculosis germs works synergistically with IL-18 for induction of IFN-R and GM-CSF, and induces the Th1-type immune response. 33 GM-CSF increased the number of CD4/CD8 DP monocytes in a dose-dependent manner in vitro ( Figure 3E ). These findings suggested that the secretion of GM-CSF induced by immunization with the killed tuberculosis germs triggered the expansion of CD4/CD8 DP monocytes in peripheral blood. The kinetics of expansion suggests that an increase in the number of CD4/CD8 DP monocytes occurs in the early phase of inflammation.
To examine whether CD4/CD8 DP cells are derived from DP monocytes in blood or are generated in situ from resident macrophages, we transferred GFP-positive spleen cells into GFP-negative recipients that had been immunized with myosin in advance ( Figures 6A and 6B ).
This adoptive transfer experiments clearly indicate that tissue-infiltrating CD4/CD8 DP macrophages are of hematogeous origin. Consistent with this observation, CD4/CD8 DP macrophages in situ did not express ED-2 (a marker for tissue-resident macrophages) or OX-62 (a marker for DCs). Thus, overall data indicate that certain stimuli that induce the release of GM-CSF trigger the expansion of CD4/CD8 DP monocytes in peripheral blood, and that these cells migrate to the site of inflammation and differentiate into macrophages displaying the Th1-type immune response and a cytotoxic phenotype. In line with these findings, CD4/CD8 DP monocytes could kill allogenic tumor cells in vitro ( Figure 6E ). This killing is unlikely to be mediated by the CTLs contaminated in the effector cells, because CTLs can kill only MHC-matched targets. In addition, we demonstrated that CD4/CD8 DP monocytes were equipped with phagocytic activities comparable to those of CD4 single-positive monocytes ( Figure 6F ).
Interestingly, human peripheral blood also contains CD14 + monocytes expressing both CD4 and CD8 (Figure 7) . In this regard, it is notable that CD4/CD8 DP macrophage/dendritic cells, which express Fas L more abundantly than other macrophages, have been identified in the thyroid glands of patients with autoimmune thyroid diseases. 43 Although the information available on their surface markers and cytokine profiles precludes us from drawing any conclusions, it is possible that they are derived from the DP monocytes identified in this study.
All volunteers participated in this study were healthy donors. No one apparently suffered from inflammatory, autoimmune or neoplastic disorders. It is of great interest to examine whether a population of CD4/CD8 DP monocytes is increased in blood under infectious or other disease conditions. Studies along this line are ongoing using clinical samples. Whereas rat DP monocytes displayed cytotoxicity against allogenic tumor cells ( Figure 6E ), we have thus far been unable to demonstrate cytotoxic activities for human CD4/CD8 DP monocytes. This may be related to the fact that human DP monocytes were isolated from healthy volunteers, whereas rat DP monocytes were isolated from animals whose immune systems were activated by the transgene or artificial immunization. Studies are in progress to understand whether the rat and human CD4/CD8 DP monocytes/macrophages have any specialized roles in host defense against infection or cancer, and in the pathogenesis of autoimmune disorders. concentrations. We chose these cytokines because they are known to be induced by BCG. [31] [32] [33] Twenty-four hours later, the percentage of CD8 beads/300 µl blood). After incubation for 2 hours at 37MC, PE-conjugated anti-CD4 (OX- 35) and PerCP-conjugated anti-CD8 (OX-8) Abs were added to the mixture, followed by depletion of erythrocytes. After 3 times wash with cold PBS, CD4/CD8 DP cells were gated to determine uptake of the fluorescence-labeled beads using FACScan. Experiments were done in triplicate.
Representative results are shown. The painted and gray histograms represent the profiles of CD4/CD8 DP and CD4 single-positive monocytes, respectively. 
